Fannie Mae, Freddie Mac shares tumble after conservatorship comments
LONDON - Medical (TASE:BLWV) technology company Smith+Nephew (LSE:SN, NYSE:SNN) will release its second quarter trading and first half 2025 financial results on Tuesday, August 5, 2025, at 7:00am BST, according to a company statement issued Monday.
The results will cover the period ended June 28, 2025. Following the announcement, Smith+Nephew will host a conference call for financial analysts at 8:30am BST.
The London-based company, which specializes in orthopedics, sports medicine, ENT, and advanced wound management, operates in approximately 100 countries with a workforce of 17,000 employees.
Smith+Nephew reported annual sales of $5.8 billion in 2024. The company focuses on medical technology for the repair, regeneration, and replacement of soft and hard tissue.
The announcement follows the company’s first quarter results, where it had previously indicated the timing of its second quarter reporting.
Smith+Nephew is listed on both the London Stock Exchange (LON:LSEG) as a constituent of the FTSE100 and on the New York Stock Exchange.
This information was provided in a press release issued by Smith+Nephew.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.